Short description
AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
Description
AlgoTx creates solutions to help patients suffering from difficult-to-treat conditions. The organization accomplishes this by emphasizing conditions with no proven or licensed therapy and adapting treatment to the very particular needs of the people afflicted. ATX01's admission into Phase 2 in Chemotherapy-Induced Peripheral Neuropathy has been approved by the FDA. In the meanwhile, AlgoTx is investigating its potential in erythromelalgia, a rare and painful condition.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Suresnes, Ile-de-France, France, Europe
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Uh Ohhhh, Noaccess, Blurry Noaccess, Blurry Noaccess, Blurry Noaccess
Sign in for full access
Founders
Olivier Bohuon, Stéphane Thiroloix